E
Excelsior Medical Co Ltd
TWSE:4104
Excelsior Medical Co Ltd
TWSE:4104
Price:
89.2 TWD
0.11%
Market Closed
Updated:
Jun 3, 2024
P/E
Price to Earnings
Price to Earnings
18.6
Current
15.2
Median
23.8
Industry
Higher
than median
Lower
than industry value
Price to Earnings (P/E) ratio is a valuation multiple that compares a company’s market capitalization to its net income. It indicates the dollar amount an investor can expect to invest in a company in order to receive $1 of that company’s earnings.
P/E
=18.6
Market Cap
/
13.9B
Net Income
746.6m
All Countries
| Market Cap | P/E | ||||
|---|---|---|---|---|---|
| TW |
E
|
Excelsior Medical Co Ltd
TWSE:4104
|
13.9B TWD | 18.6 | |
| US |
|
Mckesson Corp
NYSE:MCK
|
74B USD | 24.7 | |
| US |
|
Cencora Inc
NYSE:COR
|
45.2B USD | 24.4 | |
| US |
|
Amerisourcebergen Corp
NYSE:ABC
|
35.4B USD | 20.9 | |
| US |
|
Cardinal Health Inc
NYSE:CAH
|
24.2B USD | 43.9 | |
| US |
|
Henry Schein Inc
NASDAQ:HSIC
|
8.9B USD | 23 | |
| KR |
C
|
Celltrion Healthcare Co Ltd
KOSDAQ:091990
|
12.2T KRW | 89.6 | |
| CN |
|
Sinopharm Group Co Ltd
HKEX:1099
|
66.3B HKD | 6.8 | |
| IT |
|
Amplifon SpA
MIL:AMP
|
7.5B EUR | 46.8 | |
| CN |
|
Huadong Medicine Co Ltd
SZSE:000963
|
55B CNY | 18.7 | |
| CN |
|
Shanghai Pharmaceuticals Holding Co Ltd
SSE:601607
|
51.7B CNY | 13.6 |
P/E Forward Multiples
Forward P/E multiple is a version of the P/E ratio that uses forecasted net income for the P/E calculation. 1-Year, 2-Years, and 3-Years forwards use net income forecasts for 1, 2, and 3 years ahead, respectively.
1-Year Forward
P/E
N/A
2-Years Forward
P/E
N/A
3-Years Forward
P/E
N/A
You don't have any saved screeners yet
